Your session is about to expire
← Back to Search
Difamilast Ointment for Atopic Dermatitis
Study Summary
This trial tests a new ointment to treat skin conditions in kids aged 2+ with mild to moderate severity.
- Atopic Dermatitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Who is running the clinical trial?
Media Library
- You have been diagnosed with atopic dermatitis (AD) based on the diagnostic criteria of the American Academy of Dermatology.You are male or female at least 2 years of age.You currently have a skin infection or an active rash from conditions like herpes or chickenpox.Subjects and/or their parent(s)/legal guardian(s) (if subject is under the legal age of consent) must provide written informed consent prior to the conduct of any study-related procedures.You have a skin condition called AD that affects between 5% to 40% of your body, excluding your scalp.Subjects who have an AD Severity of mild (2) or moderate (3) as measured by the IGA of AD Severity score at screening and baseline visit.Your atopic dermatitis (AD) has improved on its own between the screening and baseline visits.You have serious feelings of sadness and thoughts of hurting yourself before or during the study.You have been diagnosed with Alzheimer's disease at least 6 months before the screening visit.You have a history of heavy drinking or using illegal drugs in the past 6 months.
- Group 1: Difamilast Ointment
- Group 2: Vehicle Controlled
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Where can I find a list of all the places where this research is taking place?
"There are 13 locations across the country where elite patients can participate in this study, including Elite Clinical Studies, LLC in Phoenix, Arizona, Dermatology Research Associates in Los Angeles, California, and Shahram Jacobs, MD Inc. in Sherman Oaks, Florida."
Is this study currently enrolling participants?
"Yes, the trial is currently looking for participants. The original posting was on October 1st, 2022, and the most recent update was on November 7th, 2022. The trial is looking for 336 participants total, which will be recruited from 13 different sites."
What is the official standing of Difamilast Ointment in the United States?
"There is some prior clinical data to support the efficacy of Difamilast Ointment, and thus it received a score of 3."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Houston Center for Clinical Research: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger